Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among


Journal

The breast journal
ISSN: 1524-4741
Titre abrégé: Breast J
Pays: United States
ID NLM: 9505539

Informations de publication

Date de publication:
2022
Historique:
received: 10 08 2022
accepted: 03 10 2022
entrez: 9 11 2022
pubmed: 10 11 2022
medline: 11 11 2022
Statut: epublish

Résumé

While To assess the rate of detection over a 5-year period, and MRI imaging features of pure noncalcified DCIS in a cohort of Israeli All female 18/121 (15.2%) participating MRI-detected noncalcified DCIS is more frequent in

Sections du résumé

Background
While
Objective
To assess the rate of detection over a 5-year period, and MRI imaging features of pure noncalcified DCIS in a cohort of Israeli
Materials and Methods
All female
Results
18/121 (15.2%) participating
Conclusion
MRI-detected noncalcified DCIS is more frequent in

Identifiants

pubmed: 36349178
doi: 10.1155/2022/4317693
pmc: PMC9633198
doi:

Substances chimiques

BRCA1 protein, human 0
BRCA1 Protein 0
BRCA2 protein, human 0
BRCA2 Protein 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4317693

Informations de copyright

Copyright © 2022 Renata Faermann et al.

Déclaration de conflit d'intérêts

The authors declare that there are no conflicts of interest.

Références

Lancet. 1996 Aug 10;348(9024):408
pubmed: 8709756
J Clin Oncol. 2002 Jun 1;20(11):2736-44
pubmed: 12039936
J Magn Reson Imaging. 2019 Aug;50(2):377-390
pubmed: 30659696
J Clin Oncol. 2010 Dec 20;28(36):5265-73
pubmed: 21079137
J Clin Oncol. 2007 Feb 20;25(6):642-7
pubmed: 17210933
J Transl Med. 2015 Oct 24;13:335
pubmed: 26496879
JAMA. 2004 Sep 15;292(11):1317-25
pubmed: 15367553
Radiology. 2004 Dec;233(3):830-49
pubmed: 15486214
Cancer Prev Res (Phila). 2009 Feb;2(2):122-7
pubmed: 19174581
J Cancer Res Clin Oncol. 2008 Oct;134(10):1113-21
pubmed: 18392852
J Clin Oncol. 2003 Jan 1;21(1):41-5
pubmed: 12506168
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
J Clin Oncol. 2002 Mar 15;20(6):1480-90
pubmed: 11896095
N Engl J Med. 2004 Apr 1;350(14):1430-41
pubmed: 15070793
Genet Test. 1997;1(1):47-51
pubmed: 10464625
Cancer. 2003 Apr 1;97(7):1601-8
pubmed: 12655515
Eur Radiol. 2020 Feb;30(2):767-777
pubmed: 31529255
J Clin Oncol. 2011 May 1;29(13):1664-9
pubmed: 21444874
Lancet. 1997 May 24;349(9064):1505-10
pubmed: 9167459
Cancer. 2012 Mar 15;118(6):1515-22
pubmed: 22009639
Am J Hum Genet. 1999 Apr;64(4):963-70
pubmed: 10090881
Eur J Cancer. 2006 Oct;42(15):2492-8
pubmed: 16908132
Breast Cancer Res Treat. 2017 Jun;163(3):565-571
pubmed: 28343309
Nat Rev Cancer. 2004 Sep;4(9):665-76
pubmed: 15343273
Mol Genet Genomic Med. 2019 Mar;7(3):e493
pubmed: 30652428
Am J Hum Genet. 1998 Mar;62(3):676-89
pubmed: 9497246

Auteurs

Renata Faermann (R)

Meirav Center for Women's Health and High-Risk Clinic, Sheba Medical Center, Ramat Gan, Israel.
Division of Diagnostic Imaging, Sheba Medical Center, Ramat Gan, Affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Eitan Friedman (E)

Meirav Center for Women's Health and High-Risk Clinic, Sheba Medical Center, Ramat Gan, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Orit Kaidar-Person (O)

Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Department of Radiation Oncology, Sheba Medical Center, Ramat Gan, Israel.

Jonathan Weidenfeld (J)

Department of Pathology, Sheba Medical Center, Ramat Gan, Israel.

Malka Brodsky (M)

Meirav Center for Women's Health and High-Risk Clinic, Sheba Medical Center, Ramat Gan, Israel.

Anat Shalmon (A)

Meirav Center for Women's Health and High-Risk Clinic, Sheba Medical Center, Ramat Gan, Israel.
Division of Diagnostic Imaging, Sheba Medical Center, Ramat Gan, Affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Osnat Halshtok Neiman (O)

Meirav Center for Women's Health and High-Risk Clinic, Sheba Medical Center, Ramat Gan, Israel.
Division of Diagnostic Imaging, Sheba Medical Center, Ramat Gan, Affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Michael Gotlieb (M)

Meirav Center for Women's Health and High-Risk Clinic, Sheba Medical Center, Ramat Gan, Israel.
Division of Diagnostic Imaging, Sheba Medical Center, Ramat Gan, Affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Yael Yagil (Y)

Meirav Center for Women's Health and High-Risk Clinic, Sheba Medical Center, Ramat Gan, Israel.
Division of Diagnostic Imaging, Sheba Medical Center, Ramat Gan, Affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

David Samoocha (D)

Meirav Center for Women's Health and High-Risk Clinic, Sheba Medical Center, Ramat Gan, Israel.
Division of Diagnostic Imaging, Sheba Medical Center, Ramat Gan, Affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Dana Madorsky Feldman (D)

Meirav Center for Women's Health and High-Risk Clinic, Sheba Medical Center, Ramat Gan, Israel.

Miri Sklair-Levy (M)

Meirav Center for Women's Health and High-Risk Clinic, Sheba Medical Center, Ramat Gan, Israel.
Division of Diagnostic Imaging, Sheba Medical Center, Ramat Gan, Affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH